Clinical Trial

Liquid Biopsy in Mature B-cell Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-09-08; most recent amendment 2026-07-07.
Trial Details
NCT Number NCT03280394
Lead Sponsor Oncology Institute of Southern Switzerland
Conditions Mature B-Cell Neoplasm
Enrollment 444 participants
Start Date 2017-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-09